Rocket Pharmaceuticals, Inc.
NASDAQ: RCKT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gaurav D. Shah
- Employees
- 299
- Headquarters
- Cranbury, United States
- IPO year
- 2015
- Market cap
- $360.3M
- Website
- https://rocketpharma.com
Loading RCKT…
Loading profile data…Frequently asked questions about RCKT
What does Rocket Pharmaceuticals, Inc. (RCKT) do?
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs. It is currently progressing three ex vivo lentiviral vector therapies aimed at...
Where does RCKT trade?
Rocket Pharmaceuticals, Inc. (RCKT) trades on the NASDAQ Global Market.
What sector is RCKT in?
Rocket Pharmaceuticals, Inc. (RCKT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Rocket Pharmaceuticals, Inc.?
Gaurav D. Shah is the chief executive officer of Rocket Pharmaceuticals, Inc. (RCKT).
Where is Rocket Pharmaceuticals, Inc. headquartered?
Rocket Pharmaceuticals, Inc. is headquartered in United States.
Does RCKT pay a dividend?
Rocket Pharmaceuticals, Inc. (RCKT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RCKT go public?
Rocket Pharmaceuticals, Inc. (RCKT) completed its initial public offering in 2015.